Humacyte (NASDAQ:HUMA) 주식

Humacyte

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

News

Politics

Personal Finance

ARKK

HUMA

INTC

PARA

PARAA

SOLV

SSBK

미국 의회 의원들의 주식 거래 활동은 위원회 임무를 포함한 이해 상충이 거래에 영향을 미칠 수 있다는 가능성으로 인해 투자자들로부터 지속적으로 관심을 끌고 있다. 잘 알려진 한 의회 의원은 금요일 시장 마감 무렵에 여러 거래를 공개했다.

미 상원 의원 토미 튜버빌은 여러 대형주의 매도와 매수 포지션 공개

Humacyte Inc

HUMAN PHEROMONE SCIENCE by Human Pheromone Sciences, Inc.

Human - United States Dollar

HUMAN HOLDINGS CO LTD by Human Holdings Co., Ltd.

Human Holdings Co Ltd

HUMAN UNITEC INTL INC by Human Unitec International, Inc.

Human Unitec International Inc

Humana Inc

Humanigen Inc

Humankind US Stock ETF

Humanscape

Humatech Inc

Biotech

General

ATYR

aTyr Pharma Announces Fourth DSMB Review For Efzofitimod In Phase 3 EFZO-FIT Study In Pulmonary Sarcoidosis

Black Diamond Therapeutic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDTX#NASDAQ">BDTX</a>) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 17.65 percent increase over losses of $(0.34) per share from the same period last year.

Earnings

Earnings Beats

BDTX

Black Diamond Therapeutic Q4 EPS $(0.28) Beats $(0.31) Estimate

Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.44) by 152.27 percent. This is a 246.88 percent decrease over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $22.800 million which missed the analyst consensus estimate of $44.650 million by 48.94 percent. This is a 32.92 percent decrease over sales of $33.989 million the same period last year.

Earnings Misses

ARCT

Arcturus Therapeutics Q4 2024 GAAP EPS $(1.11) Misses $(0.44) Estimate, Sales $22.800M Miss $44.650M Estimate

WIIM

SCPH

scPharmaceuticals shares are trading higher after the company announced FDA approval for a supplemental new drug application expanding the FUROSCIX indication to include the treatment of edema in patients with chronic kidney disease.

American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.54 by 16.67 percent. The company reported quarterly sales of $164.11 million which beat the analyst consensus estimate of $161.70 million by 1.49 percent. This is a 7.40 percent increase over sales of $152.80 million the same period last year.

APEI

American Public Education Q4 2024 GAAP EPS $0.63 Beats $0.54 Estimate, Sales $164.11M Beat $161.70M Estimate

scPharmaceuticals Announces FDA Approval For Supplemental New Drug Application Expanding FUROSCIX Indication To Include Treatment Of Edema In Patients With Chronic Kidney Disease

Contracts

Leonardo DRS Announces Delivery Of Its First Next-Generation Integrated Voice Communication Systems In Support Of The U.S. Navy's Arleigh Burke DDG51-Class Destroyers

Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 55 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $26.55 million which beat the analyst consensus estimate of $6.48 million by 309.78 percent. This is a 3.68K percent increase over sales of $702.00 thousand the same period last year.

LXRX

Lexicon Pharmaceuticals Q4 EPS $(0.09) Beats $(0.12) Estimate, Sales $26.55M Beat $6.48M Estimate

AppLovin has held up during a very volatile March. The broad markets sit below the 50-day daily simple moving average but have been holding weekly support lines in the sand.
Today we&#8217;re getting the non-farm payroll (NFP) data which might create another series of whipsaws into resistance and down into deep weekly support. In a very short-term setup we are looking at a market that can give us either move, so we are going to position into the event and then cover after the NFP numbers on Friday.
Here&#8217;s how to do that for maximum profit.
AppLovin&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) relative resistance zone sits right around $350, but a wider range into the shock move around NFP is expected. The relative support is near $300 but could easily dip to $280.&nbsp;
That makes a double butterfly the best way to structure our trade. The goal is to keep an eye on the middle strikes with alerts and sell the performing butterfly at the test of the middle strike.
A double butterfly is ideal for larger anticipated moves into a catalyst like earnings or big economic releases. This setup is a combination of a long call butterfly and a long put butterfly.&nbsp;
A long call butterfly is the combination of a long call spread and a short call spread that share the same short strike. A long put butterfly is the combination of a long put spread and a short put spread that share the same short strike. They are positioned as two separate trades. 
[<a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0307&amp;utm_campaign=wallstreetadvantage">Cut Through the Market Chaos—Get One Clear Trade Every Morning</a>]
The long call butterfly (positioned for upside in the details below) – if price action is outsized, we capture $2000 less the cost of the call butterfly, currently $130, IF prices move into $340.&nbsp;
<ul>
<li>Buy to open 1 APP 21 Mar 320 calls </li>
<li>Sell to open 2 APP 21 Mar 340 calls </li>
<li>Buy to open 1 APP 21 Mar 360 calls </li>
</ul>
The long put butterfly (positioned for downside in the details below) – if price action is outsized, we capture $2000 less the cost of the put butterfly, currently $150, IF prices move into $280.&nbsp;
<ul>
<li>Buy to open 1 APP 21 Mar 300 puts </li>
<li>Sell to open 2 APP 21 Mar 280 puts </li>
<li>Buy to open 1 APP 21 Mar 260 puts </li>
</ul>
The long call butterfly holds a current debit of $1.30 at this writing and the long put butterfly holds a current debit of $1.50. Together, the total risk is the debit you have paid for both butterflies, or if you have a definitive bias, you can engage in only one of them.&nbsp;&nbsp;
The total highest potential profit is $20 (the distance between strikes) less the cost of the debit incurred by buying both butterflies (1.30 + 1.50 = 2.80), so $20 &#8211; $2.80 = $17.20.
It is extremely rare to collect all this premium. Instead, I like to consider 200%-300% profit of the investment but big moves can deliver much higher returns.&nbsp;
The strategy result provides only two choices to exit the trade:
<ol>
<li>To sell both butterflies when the performing butterfly moves into your target parameters – particularly once the middle strike is tested. </li>
<li>To sell both butterflies on Monday if the chart does nothing, or once your threshold for loss is hit. Mine is typically 65-70% with these positions.  </li>
</ol>
Note that the option chain I chose only gives us 15 days or so – this means that any rapid moves will shift the prices of these positions sharply.
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0307&amp;utm_campaign=wallstreetadvantage">Turn Earnings Reports Into Trading Opportunities</a>
Over 160 companies report earnings this week—including Walmart, Alibaba, and Rivian. Benzinga Edge gives you instant access to earnings surprises, market-moving insights, and expert-driven strategies to act fast. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0307&amp;utm_campaign=wallstreetadvantage">Unlock My Edge</a>
Courtesy of AppLovin Corporation

Opinion

Trading Ideas

How to Trade Today's Job Numbers

Starbucks Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) shares are trading lower Thursday following reports suggesting the company is reorganizing to hold leadership more accountable for <a href="https://www.benzinga.com/news/management/25/03/44118489/starbucks-brews-a-new-cfo-taps-nordstrom-executive-cathy-smith-amid-organizational-changes">financial and operational improvements. </a>
What To Know: According to the<a href="https://www.wsj.com/business/hospitality/starbucks-ceo-tells-workers-to-step-it-up-after-layoffs-3fdba9f3"> Wall Street Journal</a>, in his first public remarks since announcing widespread layoffs, CEO Brian Niccol addressed corporate workers on Tuesday, emphasizing the need for increased accountability and a more effective decision-making process. 
Niccol criticized the company's current operational inefficiencies, stating that Starbucks is not effective in how it implements decisions and holds leaders responsible. The message came after the company cut 1,100 corporate jobs globally, including 612 positions tied to its Seattle headquarters and remote employees.
Niccol, who took over as CEO last September, framed the situation as a critical turnaround effort. He acknowledged that while Starbucks has made some progress — such as reintroducing self-service condiment bars and ceramic cups — deeper changes are required at the corporate level to restore long-term growth.
Starbucks has faced four consecutive quarters of declining same-store sales as customers increasingly choose faster and more affordable alternatives. Niccol said the recent job cuts were not primarily aimed at reducing costs but were necessary to restructure leadership for better performance. He indicated there are no immediate plans for further layoffs but stressed the need for improved operations to avoid future cuts.
The company is also pushing for more in-office work, with about 40% of its North American corporate employees currently working remotely. Niccol argued that having more employees present in Starbucks's U.S. and Canadian offices would enhance collaboration and problem-solving.
Addressing practical issues within stores, Niccol highlighted the need to address customer concerns, from fixing electrical outlets to improving the handling of drink orders. He criticized the company's tendency to rely on excessive follow-up meetings to resolve problems, calling for more decisive and proactive action.
SBUX Price Action: Starbucks shares were down 4.87% at $106.26 at publication Thursday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="526" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06145448/Screenshot-2025-03-06-at-14.54.27-1024x526.png" alt="" class="wp-image-812916" style="width:456px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06145448/Screenshot-2025-03-06-at-14.54.27-1024x526.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06145448/Screenshot-2025-03-06-at-14.54.27-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06145448/Screenshot-2025-03-06-at-14.54.27-768x394.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06145448/Screenshot-2025-03-06-at-14.54.27.png 1521w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/03/44176918/trump-delays-mexico-tariffs-for-a-month-economic-uncertainty-persits">Trump Delays Mexico Tariffs For A Month, Economic Uncertainty Persists</a></li>
</ul>
Photo: Shutterstock.

Restaurants

Management

Movers

SBUX

Starbucks Shares Fall As CEO Pushes For Accountability During Reorganization, Layoffs: What's Going On?

Oil is trading lower amid continued tariff uncertainty and OPEC+ output increase plans.

Carnival Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) shares are trading lower by 6.4% to $20.88 during Thursday&#8217;s session. Shares of travel-related companies are trading lower amid overall market weakness following a <a href="https://www.benzinga.com/quote/UTEN">rise in Treasury yields</a>. Investors may be evaluating ongoing global tension related to tariffs and conflict.
What To Know: Carnival stock declined Thursday as escalating trade tensions and new tariffs on U.S. imports from Canada, Mexico and China <a href="https://www.benzinga.com/news/global/25/03/44176918/trump-delays-mexico-tariffs-for-a-month-economic-uncertainty-persits">rattled investor confidence</a>. 
The cruise line giant, which relies heavily on international supply chains and global consumer demand, faces potential cost increases as tariffs drive up prices on key materials, fuel and ship maintenance expenses. 
Additionally, any retaliatory levies on U.S. travel services could dampen international bookings, a crucial revenue stream for Carnival.
Read Also: <a href="https://www.benzinga.com/general/market-summary/25/03/44172028/trade-turmoil-oil-slides-whats-driving-markets-thursday">Trade Turmoil, Oil Slides: What&#8217;s Driving Markets Thursday?</a>
What Else: The broader market remained in negative territory, with major indices struggling to recover from steep losses earlier in the session. While Commerce Secretary Howard Lutnick hinted at possible exemptions for certain industries and negotiations that could prevent additional tariffs, uncertainty continues to weigh on companies like Carnival.
Consumers could also feel the impact, as <a href="https://www.benzinga.com/government/regulations/25/03/44171377/retailers-warn-of-price-increases-due-to-trump-tariffs-as-consumer-health-concerns-persist">rising costs</a> may lead to higher ticket prices or reduced promotions, potentially discouraging budget-conscious travelers. If economic pressures force consumers to cut discretionary spending, demand for cruises could soften, further pressuring Carnival's revenue. 
Investors remain wary of how prolonged trade tensions might affect the company's profitability and long-term growth, particularly in emerging markets where Carnival has been expanding aggressively.
Read Also: <a href="https://www.benzinga.com/news/global/25/03/44176918/trump-delays-mexico-tariffs-for-a-month-economic-uncertainty-persits">Trump Delays Mexico Tariffs For A Month, Economic Uncertainty Persists</a>
<h2 class="wp-block-heading">How To Buy CCL Stock</h2>
By now you're likely curious about how to participate in the market for Carnival &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Carnival, which is trading at $21.05 as of publishing time, $100 would buy you 4.75 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Read Next:<a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" target="_blank" rel="noreferrer noopener">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" target="_blank" rel="noreferrer noopener">Markets Tank After Trump Confirms More Tariffs: Here's What Wall Street Is Saying</a></li>
</ul>

What's Going On With Carnival (CCL) Stock?

Deep-pocketed investors have adopted a bearish approach towards Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in QCOM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 34 extraordinary options activities for Qualcomm. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 50% bearish. Among these notable options, 20 are puts, totaling $1,156,768, and 14 are calls, amounting to $2,071,366.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $130.0 to $210.0 for Qualcomm over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Qualcomm's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Qualcomm's whale activity within a strike price range from $130.0 to $210.0 in the last 30 days. 
<h3>Qualcomm Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741294047_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$14.85</td>
<td>$13.55</td>
<td>$13.75</td>
<td>$210.00</td>
<td>$750.7K</td>
<td>4.2K</td>
<td align="right">546</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$18.5</td>
<td>$17.35</td>
<td>$17.8</td>
<td>$195.00</td>
<td>$315.0K</td>
<td>2.5K</td>
<td align="right">354</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$17.5</td>
<td>$15.65</td>
<td>$16.95</td>
<td>$195.00</td>
<td>$300.0K</td>
<td>2.5K</td>
<td align="right">0</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$25.5</td>
<td>$25.2</td>
<td>$25.43</td>
<td>$170.00</td>
<td>$264.3K</td>
<td>3.0K</td>
<td align="right">17</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$27.85</td>
<td>$26.9</td>
<td>$27.2</td>
<td>$130.00</td>
<td>$168.6K</td>
<td>101</td>
<td align="right">62</td>
</tr>
</tbody>
</table>

<h3>About Qualcomm</h3>
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
Following our analysis of the options activities associated with Qualcomm, we pivot to a closer look at the company's own performance.
<h3>Current Position of Qualcomm</h3>
<ul>
<li>Currently trading with a volume of 4,600,623, the QCOM's price is down by -1.54%, now at $156.04. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 55 days.</li>
</ul>
<h3>Professional Analyst Ratings for Qualcomm</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $203.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Neutral with a price target of $160. 
&#x2A; An analyst from Benchmark downgraded its action to Buy with a price target of $240. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their In-Line rating on Qualcomm, which currently sits at a price target of $179. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Qualcomm, maintaining a target price of $190. 
&#x2A; An analyst from Rosenblatt has decided to maintain their Buy rating on Qualcomm, which currently sits at a price target of $250. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Qualcomm, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

QCOM

A Closer Look at Qualcomm's Options Market Dynamics

Investors with a lot of money to spend have taken a bullish stance on SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SOUN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 17 uncommon options trades for SoundHound AI.
This isn't normal.
The overall sentiment of these big-money traders is split between 47% bullish and 41%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $478,050, and 10 are calls, for a total amount of $662,817.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $8.0 to $17.0 for SoundHound AI during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in SoundHound AI's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to SoundHound AI's substantial trades, within a strike price spectrum from $8.0 to $17.0 over the preceding 30 days.
<h3>SoundHound AI Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741294041_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$1.72</td>
<td>$1.68</td>
<td>$1.72</td>
<td>$8.00</td>
<td>$192.9K</td>
<td>98</td>
<td>1.1K</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$7.6</td>
<td>$7.35</td>
<td>$7.5</td>
<td>$17.00</td>
<td>$123.0K</td>
<td>314</td>
<td>300</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$3.15</td>
<td>$3.05</td>
<td>$3.15</td>
<td>$13.00</td>
<td>$94.3K</td>
<td>211</td>
<td>301</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$2.45</td>
<td>$2.44</td>
<td>$2.45</td>
<td>$12.00</td>
<td>$85.7K</td>
<td>1.4K</td>
<td>500</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$0.72</td>
<td>$0.7</td>
<td>$0.72</td>
<td>$12.00</td>
<td>$72.1K</td>
<td>6.8K</td>
<td>3.1K</td>
</tr>
</tbody>
</table>

<h3>About SoundHound AI</h3>
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.
Having examined the options trading patterns of SoundHound AI, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is SoundHound AI Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 23,166,665, with SOUN's price down by -7.09%, positioned at $9.43.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 63 days.</li>
</ul>
<h3>Expert Opinions on SoundHound AI</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $19.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from HC Wainwright &amp; Co. lowers its rating to Buy with a new price target of $26. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Buy rating for SoundHound AI, targeting a price of $13. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SoundHound AI, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

SOUN

Spotlight on SoundHound AI: Analyzing the Surge in Options Activity

Deep-pocketed investors have adopted a bullish approach towards On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ONON usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for On Holding. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 63% leaning bullish and 27% bearish. Among these notable options, 4 are puts, totaling $529,156, and 7 are calls, amounting to $606,207.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $45.0 to $52.5 for On Holding during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in On Holding's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to On Holding's substantial trades, within a strike price spectrum from $45.0 to $52.5 over the preceding 30 days.
<h3>On Holding Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741294035_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.18</td>
<td>$2.1</td>
<td>$2.17</td>
<td>$52.50</td>
<td>$325.5K</td>
<td>2.0K</td>
<td>1.6K</td>
</tr>
<tr>
<td>ONON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$3.65</td>
<td>$3.6</td>
<td>$3.6</td>
<td>$50.00</td>
<td>$247.7K</td>
<td>1.0K</td>
<td>711</td>
</tr>
<tr>
<td>ONON</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$4.4</td>
<td>$4.2</td>
<td>$4.35</td>
<td>$45.00</td>
<td>$123.5K</td>
<td>980</td>
<td>1.0K</td>
</tr>
<tr>
<td>ONON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$3.6</td>
<td>$3.55</td>
<td>$3.55</td>
<td>$50.00</td>
<td>$121.0K</td>
<td>1.0K</td>
<td>1.1K</td>
</tr>
<tr>
<td>ONON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$9.95</td>
<td>$8.95</td>
<td>$9.95</td>
<td>$50.00</td>
<td>$104.4K</td>
<td>63</td>
<td>0</td>
</tr>
</tbody>
</table>

<h3>About On Holding</h3>
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.
<h3>Where Is On Holding Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,215,606, the ONON's price is down by -5.91%, now at $49.38. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 68 days.</li>
</ul>
<h3>What The Experts Say On On Holding</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $67.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on On Holding with a target price of $66. 
&#x2A; An analyst from Telsey Advisory Group has decided to maintain their Outperform rating on On Holding, which currently sits at a price target of $67. 
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on On Holding, maintaining a target price of $67. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on On Holding with a target price of $73. 
&#x2A; Consistent in their evaluation, an analyst from Williams Trading keeps a Buy rating on On Holding with a target price of $62. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest On Holding options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

ONON

On Holding Unusual Options Activity

Macro Economic Events

Economics

Federal Reserve

Fed's Waller Says Being Able To Fire Fed Officials May Not Lead To Best Policy Outcomes; Past Trump Tariffs Were More Modest, Very Little Was Passed Through; It's Very Hard To Eat A 25% Tariff; Current Trump Tariff Regime Doesn't Compared With First Iteration

Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares are trading higher Thursday after falling Wednesday following a fourth-<a href="https://www.benzinga.com/news/earnings/25/03/44153467/rigetti-computing-q4-earnings-revenue-miss-quanta-computer-collaboration-highlights">quarter revenue miss.</a>
What To Know: Rigetti reported fourth-quarter revenue of $2.3 million, falling short of analyst expectations of $2.5 million, according to Benzinga Pro. The company's adjusted loss per share came in at 8 cents, matching analyst estimates. 
Following the quarter's end, Rigetti entered an agreement with Quanta Computer, a Taiwan-based company known for its leadership in computer server manufacturing. Both companies plan to invest over $100 million each over the next five years as part of the collaboration. Quanta will also invest $35 million directly into Rigetti common shares.
Rigetti CEO Dr. Subodh Kulkarni said the collaboration is intended to strengthen both companies' positions in the growing quantum computing market. The partnership aims to leverage their combined expertise to advance quantum computing technology.
The company also highlighted the December 2024 launch of its 84-qubit Ankaa-3 system. This system is now accessible to Rigetti's partners through its Quantum Cloud Services platform and is available to the public through Amazon Bracket and Microsoft Azure. 
RGTI Price Action: Rigetti shares were up 4% at $8.51 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072624&amp;t=be2bearmibe3na1">Benzinga pro</a>.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="520" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06142351/Screenshot-2025-03-06-at-14.23.24-1024x520.png" alt="" class="wp-image-812866" style="width:504px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06142351/Screenshot-2025-03-06-at-14.23.24-1024x520.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06142351/Screenshot-2025-03-06-at-14.23.24-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06142351/Screenshot-2025-03-06-at-14.23.24-768x390.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06142351/Screenshot-2025-03-06-at-14.23.24-1536x779.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06142351/Screenshot-2025-03-06-at-14.23.24.png 1547w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44172028/trade-turmoil-oil-slides-whats-driving-markets-thursday">Trade Turmoil, Oil Slides: What&#8217;s Driving Markets Thursday?</a></li>
</ul>
Image Created Via Midjourney.

RGTI

Rigetti Computing Stock Rises After Decline On Q4 Revenue Miss: What's Going On?

McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) has outperformed the market over the past 10 years by 1.73% on an annualized basis producing an average annual return of 12.59%. Currently, McDonald's has a market capitalization of $222.13 billion. 
Buying $100 In MCD: If an investor had bought $100 of MCD stock 10 years ago, it would be worth $322.83 today based on a price of $310.90 for MCD at the time of writing.
<h3>McDonald's's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741293910_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

<a href="https://nypost.com/2025/03/06/business/harry-styles-nearing-deal-for-35-show-residency-at-james-dolans-las-vegas-sphere-sources/" title="https://nypost.com/2025/03/06/business/harry-styles-nearing-deal-for-35-show-residency-at-james-dolans-las-vegas-sphere-sources/">https://nypost.com/2025/03/06/business/harry-styles-nearing-deal-for-35-show-residency-at-james-dolans-las-vegas-sphere-sources/</a>

SPHR

Watching Sphere Entertainment; Shares See Volume, Traders Circulate NY Post Article Titled "Harry Styles nearing deal for 35-show residency at James Dolan's Las Vegas Sphere"

Fed's Waller Says 80K-100K Is Likely Break Even For Job Market; Job Market Conditions More Closely Resemble Pre-Pandemic Times

Penny Stocks

Small Cap

Press Releases

HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Health Care

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Legal

DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Comments

Humacyte

뉴스

파트너 / 기고자

벤징가 글로벌